Patients scramble as cheaper obesity drug alternatives disappear

March 20, 2025

A picture of a slide adjusting scale

(NPR) – “It is completely life-changing to take a bite of these triggering foods and just be like, enjoy it, say, ‘Yup, that was good and now I’m full,'” he says.

But the compounded drugs that the Agars and others have come to rely on aren’t here to stay.

The FDA says compounding pharmacies have to stop making tirzepatide because the agency has declared the yearlong Zepbound shortage over. The deadline is Wednesday. (Read More)

Posted by

Posted in News, Pharma